Xu H - Search Results

1

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions.

Gao L, Xu H, Ye Q, Li S, Wang J, Mei Y, Niu C, Kang T, Chen C, Wang Y. Gao L, et al. Among authors: xu h. Front Pharmacol. 2020 May 5;11:552. doi: 10.3389/fphar.2020.00552. eCollection 2020. Front Pharmacol. 2020. PMID: 32431611 Free PMC article.

2

Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.

Peng J, Zhang HN, Liu ZS, Xu H, Wang Y. Peng J, et al. Among authors: xu h. Int J Clin Pharmacol Ther. 2014 Aug;52(8):684-92. doi: 10.5414/CP202078. Int J Clin Pharmacol Ther. 2014. PMID: 24887335

3

Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.

Wang Y, Zhang HN, Niu CH, Gao P, Chen YJ, Peng J, Liu MC, Xu H. Wang Y, et al. Among authors: xu h. Acta Pharmacol Sin. 2014 Oct;35(10):1342-50. doi: 10.1038/aps.2014.76. Epub 2014 Sep 15. Acta Pharmacol Sin. 2014. PMID: 25220641 Free PMC article.

4

Pharmacokinetic Characteristics and Clinical Outcomes of Vancomycin in Young Children With Various Degrees of Renal Function.

Zhang H, Wang Y, Gao P, Hu J, Chen Y, Zhang L, Shen X, Xu H, Xu Q. Zhang H, et al. Among authors: xu q, xu h. J Clin Pharmacol. 2016 Jun;56(6):740-8. doi: 10.1002/jcph.653. Epub 2015 Dec 21. J Clin Pharmacol. 2016. PMID: 26440302

5

Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients.

Li SC, Ye Q, Xu H, Zhang L, Wang Y. Li SC, et al. Among authors: xu h. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02387-18. doi: 10.1128/AAC.02387-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30642929 Free PMC article.

6

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation.

Niu CH, Xu H, Gao LL, Nie YM, Xing LP, Yu LP, Wu SL, Wang Y. Niu CH, et al. Among authors: xu h. Front Pharmacol. 2020 Mar 2;11:184. doi: 10.3389/fphar.2020.00184. eCollection 2020. Front Pharmacol. 2020. PMID: 32194415 Free PMC article.

7

Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes.

Peng H, Gao P, Xu Q, Liu M, Peng J, Wang Y, Xu H. Peng H, et al. Among authors: xu q, xu h. J Clin Virol. 2020 Jul;128:104425. doi: 10.1016/j.jcv.2020.104425. Epub 2020 May 7. J Clin Virol. 2020. PMID: 32446167 Free PMC article.

8

Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.

Wang J, Li SC, Ye Q, Gao LL, Nie YM, Xu H, Wu M, Cao P, Wang Y. Wang J, et al. Among authors: xu h. J Clin Pharmacol. 2020 Sep;60(9):1220-1230. doi: 10.1002/jcph.1618. Epub 2020 Jun 2. J Clin Pharmacol. 2020. PMID: 32488878

9

Existing drug treatments cannot significantly shorten the clinical cure time of children with COVID-19.

Li M, Wang Y, Xu H, Liu C, Shi L, Ye Q, Wang J, Li S, Mei Y, Gao L. Li M, et al. Among authors: xu h. J Infect Dev Ctries. 2020 Sep 30;14(9):963-967. doi: 10.3855/jidc.13491. J Infect Dev Ctries. 2020. PMID: 33031081 Free article.

10

Astragaloside IV Alleviates Tacrolimus-Induced Chronic Nephrotoxicity via p62-Keap1-Nrf2 Pathway.

Gao P, Du X, Liu L, Xu H, Liu M, Guan X, Zhang C. Gao P, et al. Among authors: xu h. Front Pharmacol. 2021 Jan 18;11:610102. doi: 10.3389/fphar.2020.610102. eCollection 2020. Front Pharmacol. 2021. PMID: 33536919 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,710 results

Search Page

Filters